240 related articles for article (PubMed ID: 21062482)
61. Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: an in vivo study on 29 tumors.
Brieger J; Weidt EJ; Schirmacher P; Störkel S; Huber C; Decker HJ
J Mol Med (Berl); 1999 Jun; 77(6):505-10. PubMed ID: 10475065
[TBL] [Abstract][Full Text] [Related]
62. Immunohistochemical demonstration of angiogenesis-associated homeobox proteins in canine vascular tumours.
Kodama A; Sakai H; Murakami M; Murai A; Mori T; Maruo K; Yanai T; Masegi T
J Comp Pathol; 2009; 141(2-3):199-203. PubMed ID: 19505696
[TBL] [Abstract][Full Text] [Related]
63. Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.
Wang G; Wu M; Durham AC; Radaelli E; Mason NJ; Xu X; Roth DB
PLoS One; 2020; 15(3):e0229728. PubMed ID: 32210430
[TBL] [Abstract][Full Text] [Related]
64. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
65. [Mutation of von Hippel-Lindau gene and expression of vascular endothelial growth factor in sporadic clear cell renal cell carcinoma and their relationships to angiogenesis].
Zhang N; Gong K; Guo HF; Na X; Wu G; Yang XY; Xin DQ; Na YQ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1620-4. PubMed ID: 15569457
[TBL] [Abstract][Full Text] [Related]
66. 2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma.
Nagaprashantha LD; Vatsyayan R; Singhal J; Lelsani P; Prokai L; Awasthi S; Singhal SS
Carcinogenesis; 2011 Apr; 32(4):568-75. PubMed ID: 21304051
[TBL] [Abstract][Full Text] [Related]
67. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
[TBL] [Abstract][Full Text] [Related]
68. Endothelial function of von Hippel-Lindau tumor suppressor gene: control of fibroblast growth factor receptor signaling.
Champion KJ; Guinea M; Dammai V; Hsu T
Cancer Res; 2008 Jun; 68(12):4649-57. PubMed ID: 18559510
[TBL] [Abstract][Full Text] [Related]
69. Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis.
Kurban G; Hudon V; Duplan E; Ohh M; Pause A
Cancer Res; 2006 Feb; 66(3):1313-9. PubMed ID: 16452184
[TBL] [Abstract][Full Text] [Related]
70. The role of hypoxia in 2-butoxyethanol-induced hemangiosarcoma.
Laifenfeld D; Gilchrist A; Drubin D; Jorge M; Eddy SF; Frushour BP; Ladd B; Obert LA; Gosink MM; Cook JC; Criswell K; Somps CJ; Koza-Taylor P; Elliston KO; Lawton MP
Toxicol Sci; 2010 Jan; 113(1):254-66. PubMed ID: 19812364
[TBL] [Abstract][Full Text] [Related]
71. Genome-wide analysis of the effect of esophageal squamous cell carcinoma on human umbilical vein endothelial cells.
Jin G; Yang Y; Liu H; Liu K; Zhao J; Chen X; Zhang X; Zhang Y; Lu J; Dong Z
Oncol Rep; 2016 Jul; 36(1):155-64. PubMed ID: 27222202
[TBL] [Abstract][Full Text] [Related]
72. Pathogenesis of human hemangiosarcomas and hemangiomas.
Liu L; Kakiuchi-Kiyota S; Arnold LL; Johansson SL; Wert D; Cohen SM
Hum Pathol; 2013 Oct; 44(10):2302-11. PubMed ID: 24054722
[TBL] [Abstract][Full Text] [Related]
73. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway.
Dong G; Loukinova E; Chen Z; Gangi L; Chanturita TI; Liu ET; Van Waes C
Cancer Res; 2001 Jun; 61(12):4797-808. PubMed ID: 11406555
[TBL] [Abstract][Full Text] [Related]
74. Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice.
Wang J; Ma Y; Jiang H; Zhu H; Liu L; Sun B; Pan S; Krissansen GW; Sun X
J Hepatol; 2011 Aug; 55(2):359-68. PubMed ID: 21168458
[TBL] [Abstract][Full Text] [Related]
75. The von Hippel-Lindau gene and protein in tumorigenesis and angiogenesis: a potential target for therapeutic designs.
Shiao YH
Curr Med Chem; 2003 Nov; 10(22):2461-70. PubMed ID: 14529485
[TBL] [Abstract][Full Text] [Related]
76. Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation.
Lamerato-Kozicki AR; Helm KM; Jubala CM; Cutter GC; Modiano JF
Exp Hematol; 2006 Jul; 34(7):870-8. PubMed ID: 16797414
[TBL] [Abstract][Full Text] [Related]
77. Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice.
Rankin EB; Rha J; Unger TL; Wu CH; Shutt HP; Johnson RS; Simon MC; Keith B; Haase VH
Oncogene; 2008 Sep; 27(40):5354-8. PubMed ID: 18490920
[TBL] [Abstract][Full Text] [Related]
78. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.
Mukhopadhyay D; Knebelmann B; Cohen HT; Ananth S; Sukhatme VP
Mol Cell Biol; 1997 Sep; 17(9):5629-39. PubMed ID: 9271438
[TBL] [Abstract][Full Text] [Related]
79. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
Prowse AH; Webster AR; Richards FM; Richard S; Olschwang S; Resche F; Affara NA; Maher ER
Am J Hum Genet; 1997 Apr; 60(4):765-71. PubMed ID: 9106522
[TBL] [Abstract][Full Text] [Related]
80. Notch2 signal is required for the maintenance of canine hemangiosarcoma cancer stem cell-like cells.
Aoshima K; Fukui Y; Gulay KCM; Erdemsurakh O; Morita A; Kobayashi A; Kimura T
BMC Vet Res; 2018 Oct; 14(1):301. PubMed ID: 30285832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]